Journals / Türk Göğüs Kalp Damar Cerrahisi Dergisi / 2008 / Cilt: 16 - Sayı: 4

Infrainguinal femoropopliteal bypass operations

Dizaltı femoropopliteal bypass girişimlerimiz

Pages
236–240
Publication Date
2022-09-02
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Adjuvant anticoagulant therapy may improve the patency rate in patients receiving a synthetic graft.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: We evaluated the results of infrainguinal femoropopliteal bypass operations.
📊
Key Findings & Data:Methods: Thirty-seven patients (30 males, 7 females; mean age 61 years; range 21 to 82 years) were retrospectively evaluated.
💡
Conclusion & Impact:Adjuvant anticoagulant therapy may improve the patency rate in patients receiving a synthetic graft.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background: We evaluated the results of infrainguinal femoropopliteal bypass operations. Methods: Thirty-seven patients (30 males, 7 females; mean age 61 years; range 21 to 82 years) were retrospectively evaluated. Clinical results and graft patencies were determined.Results: Distal anastomoses were placed at the level of popliteal artery trifurcation in 28 patients (75.7%), to the tibioperoneal trunk in one patient (2.7%), posterior tibial artery in four patients (10.8%), and anterior tibial artery in four patients. Reversed autogenous saphenous vein was used in 28 patients and polytetrafluoroethylene graft was used in nine patients. All patients receiving a synthetic graft were treated with anticoagulants. Mortality did not occur. Thrombectomy was performed in seven patients (18.9%) due to graft failure. One-year patency rate was 89.3% with autogenous saphenous veins, and 55.6% with synthetic grafts (p<0.05). Two major (5.4%) and three minor (8.1%) amputations were required.Conclusion: Reversed autogenous saphenous vein should be the graft of choice in below-knee bypass operations. Adjuvant anticoagulant therapy may improve the patency rate in patients receiving a synthetic graft.

Özet

Amaç: Bu çalışmada dizaltı femoropopliteal bypass ameliyatı uygulanan hastalarda tedavi sonuçları değerlendirildi. Çalışma planı: Çalışmada 37 hasta (30 erkek, 7 kadın; ort. yaş 61; dağılım 21-82) geriye dönük olarak değerlendirildi. Hastaların klinik durumları ve greft açıklıkları belirlendi.Bulgular: Distal anastomoz 28 hastada (%75.7) popliteal arterde trifurkasyon düzeyine, bir hastada (%2.7) tibioperoneal trunka, dört hastada (%10.8) tibialis posteriora, dört hastada ise tibialis anteriora yapıldı. Hastaların 28'inde otojen revers safen ven kullanılırken, dokuz hastada politetrafloroetilen greftler tercih edildi. Sentetik greft takılan tüm olgulara antikoagülan tedavi uygulandı. Hiçbir olguda mortalite görülmedi. Yedi hastaya (%18.9) greft yetmezliği nedeniyle trombektomi uygulandı. Bir yıllık açık kalma oranları otojen safen ven greftinde %89.3, sentetik greftlerde %55.6 (p<0.05) bulundu. İki olguda (%5.4) majör, üç olguda (%8.1) minör amputasyon gerekti.Sonuç: Dizaltı bypass uygulamalarında otojen safen ven ilk tercih edilmesi gereken grefttir. Sentetik greft kullanılan olgularda ise tedaviye antikoagülan tedavinin eklenmesiyle daha iyi açık kalma oranları elde edilebilir.

🔖

Cite This Article

AZAK, S., RAHMAN, A. (2022). Infrainguinal femoropopliteal bypass operations. Türk Göğüs Kalp Damar Cerrahisi Dergisi, Cilt: 16 - Sayı: 4, 236–240. https://ajindex.com/articles/425052

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Kurç E, Enç Y, Çınar B, Kurç P, Kösem M, Sezerman Ö. Femoropopliteal bypass cerrahisinde greft seçimimiz ve uzun dönem patency sonuçlarımız. Türk Göğüs Kalp Damar Cer Derg 200;8:616-8
  2. Veith FJ, Haimovici H. Femoropopliteal arteriosclerotic occlusive disease: In: Haimovici H, editor. Haimovici’s vascular sugery. 4th ed. Cambridge: Blackwell Science; 1996. p. 605-31
  3. Edwards WH, Mulherin JL Jr. The role of graft material in femorotibial bypass grafts. Ann Surg 1980;191:721-6
  4. Klinkert P, Post PN, Breslau PJ, van Bockel JH. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg 2004; 27:357-62
  5. Falco E, Celoria G, Nardini A, Saccomanno G, De Franchi G, Zappia F, et al. Femoro-popliteal bypass with reversed saphenous vein. Experience in a General Surgery Department. Minerva Chir 1995;50:883-8. [Abstract] 6) Plecha EJ, Freischlag JA, Seabrook GR, Towne JB. Femoropopliteal bypass revisited: an analysis of 138 cases. Cardiovasc Surg 1996;4:195-9
  6. Towne JB. The autogenous vein. In: Rutherford RB, editor. Vascular surgery. 4th ed. Philadelphia: W. B. Saunders; 1995. p. 482-91
  7. Hall KV. The great saphenous vein used in situ as an arterial shunt after extirpation of the vein valves. A preliminary report. Surgery 1962;51:492-5
  8. Lawson JA, Tangelder MJ, Algra A, Eikelboom BC. The myth of the in situ graft: superiority in infrainguinal bypass surgery? Eur J Vasc Endovasc Surg 1999;18:149-57
  9. Wengerter KR, Veith FJ, Gupta SK, Goldsmith J, Farrell E, Harris PL, et al. Prospective randomized multicenter comparison of in situ and reversed vein infrapopliteal bypasses. J Vasc Surg 1991;13:189-97
  10. Abbott WM. Prosthetic above-knee femoral-popliteal bypass: indications and choice of graft. Semin Vasc Surg 1997;10:3-7
  11. Prendiville EJ, Yeager A, O’Donnell TF Jr, Coleman JC, Jaworek A, Callow AD, et al. Long-term results with the above-knee popliteal expanded polytetrafluoroethylene graft. J Vasc Surg 1990;11:517-24
  12. Klinkert P, Schepers A, Burger DH, van Bockel JH, Breslau PJ. Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five year results of a randomized controlled trial. J Vasc Surg 2003;37:149-55
  13. Albers M, Battistella VM, Romiti M, Rodrigues AA, Pereira CA. Meta-analysis of polytetrafluoroethylene bypass grafts to infrapopliteal arteries. J Vasc Surg 2003;37:1263-9
  14. Post S, Kraus T, Muller-Reinartz U, Weiss C, Kortmann H, Quentm